|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Jounce Therapeutics Inc (JNCE) |
|
|
$1.88 0.00 (0.00%) as of 4:30 Wed 5/3
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
51,230,000 |
Market
Cap: |
96.31(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.88 - $1.88 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Jounce Therapeutics is a clinical-stage immunotherapy company focuses on the treatment of cancer by developing therapies that enable the immune system to attack tumors. Co.'s product candidates include: JTX-8064, an antibody that binds to Leukocyte Immunoglobulin Like Receptor B2; Vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells commonly found in several solid tumors; Pimivalimab, a clinical-stage anti-PD-1 antibody for potential use in combination with its product candidates; and GS-1811, a monoclonal antibody that depletes T regulatory cells in the tumor microenvironment.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
85,987 |
Total Buy Value |
$0 |
$0 |
$0 |
$85,958 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
124,313 |
Total Sell Value |
$0 |
$0 |
$0 |
$167,105 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
9 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Karsen Perry A |
Director |
|
2017-02-01 |
4 |
B |
$16.00 |
$80,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Higgons John Duncan |
Director |
|
2017-02-01 |
4 |
B |
$16.00 |
$107,200 |
D/D |
6,700 |
27,025 |
2.39 |
- |
|
Hadley Harbor Master Investors (cayman) L.p. |
10% Owner |
|
2017-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
719,476 |
719,476 |
|
- |
|
Celgene Corp /de/ |
10% Owner |
|
2017-02-01 |
4 |
B |
$16.00 |
$10,000,000 |
D/D |
625,000 |
3,456,463 |
2.45 |
- |
|
Celgene Corp /de/ |
10% Owner |
|
2017-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,831,463 |
2,831,463 |
|
- |
|
Starr Kevin P |
10% Owner |
|
2017-01-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
542,005 |
|
- |
|
Drapkin Kimberlee C |
CFO and TreasurerOfficer |
|
2017-01-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,775 |
|
- |
|
Tepper Robert I |
Director |
|
2017-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
542,005 |
|
- |
|
158 Records found
|
|
Page 7 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|